{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:31:36Z","timestamp":1740105096080,"version":"3.37.3"},"reference-count":20,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T00:00:00Z","timestamp":1404345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T00:00:00Z","timestamp":1404345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Methods Psychiatr. Res."],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1002\/mpr.1443","type":"journal-article","created":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T09:14:04Z","timestamp":1404378844000},"page":"439-450","source":"Crossref","is-referenced-by-count":3,"title":["Within\u2010drug benefit\u2010risk evaluation of olanzapine long\u2010acting injection at one and two years of treatment"],"prefix":"10.1002","volume":"23","author":[{"given":"Holland C.","family":"Detke","sequence":"first","affiliation":[{"name":"Eli Lilly and Company  Indianapolis IN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Lauriello","sequence":"additional","affiliation":[{"name":"University of Missouri Department of Psychiatry  Columbia MO USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Landry","sequence":"additional","affiliation":[{"name":"Eli Lilly Canada  Danforth Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"McDonnell","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company  Indianapolis IN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,7,3]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.3.441"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.154.5.672"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.291"},{"key":"e_1_2_10_5_1","unstructured":"Council for International Organizations of Medical Sciences Working Group IV (CIOMS). (1998)Benefit\u2010risk balance for marketed drugs: evaluating safety signals.http:\/\/www.cioms.ch\/publications\/g4\u2010benefit\u2010risk.pdf[23 April 2013]."},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-10-43"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/jcp.0000000000000140"},{"key":"e_1_2_10_8_1","unstructured":"European Medicines Agency\/Committee for Medicinal Product for Human Use (EMA CHMP). (2008)Reflection paper on benefit\u2010risk assessment methods in the context of the evaluation of marketing authorisation applications of medicinal products for human use.http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Regulatory_and_procedural_guideline\/2010\/01\/WC500069634.pdf[23 April 2013]."},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2010.00725.x"},{"key":"e_1_2_10_10_1","first-page":"534","volume-title":"Abnormal Involuntary Movement Scale (AIMS). ECDEU Assessment Manual for Psychopharmacology","author":"Guy W.A.","year":"1976"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2009.07081221"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/13.2.261"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0512"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.251"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.280"},{"key":"e_1_2_10_16_1","unstructured":"MarkowitzM. LevitanB. FuD.J. TurkozI. GopalS. HoughD. CoppolaD. AlphsL.(2011)Benefit\u2010risk assessment of maintenance therapy in schizophrenia comparing long\u2010acting injectable (LAI) paliperidone palmitate with paliperidone ER. Presented at the Annual Meeting of the American Psychiatric Association 16 May 2011 Honolulu HI Abstract NR06\u201039."},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.4137\/CMPsy.S6659"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.2466\/pr0.1962.10.3.799"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1970.tb02066.x"},{"volume-title":"SF\u201036 Health Survey Manual and Interpretation Guide","year":"1993","author":"Ware J.E.","key":"e_1_2_10_20_1"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2149"}],"container-title":["International Journal of Methods in Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmpr.1443","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmpr.1443","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mpr.1443","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/mpr.1443","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mpr.1443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T14:50:19Z","timestamp":1625410219000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mpr.1443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,3]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.1002\/mpr.1443"],"URL":"https:\/\/doi.org\/10.1002\/mpr.1443","archive":["Portico"],"relation":{},"ISSN":["1049-8931","1557-0657"],"issn-type":[{"type":"print","value":"1049-8931"},{"type":"electronic","value":"1557-0657"}],"subject":[],"published":{"date-parts":[[2014,7,3]]}}}